Labcorp Q4 FY25: where the revenue came from and where it went
The whole income statement of Labcorp for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Oct 1 – Dec 31, 2025
- Reported
- Feb 24, 2026
Revenue$3.52B
+6% year over year
Gross profit$0.99B
28% margin
Operating profit$0.27B
8% margin
Net profit$0.17B
5% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 3.52 | 100% | +6% |
| Diagnostics | 2.73 | 78% | +6% |
| Biopharma laboratory | 0.79 | 22% | +3% |
| Cost of revenue | −2.52 | 72% | |
| Gross profit | 0.99 | 28% margin | +1pp |
| SG&A | −0.54 | 16% | −3pp |
| Other | −0.19 | 5% | +0pp |
| Operating profit | 0.27 | 8% margin | +1pp |
| Interest & other costs | −0.08 | ||
| Tax | −0.03 | ||
| Net profit | 0.17 | 5% margin | +0pp |
122 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest